SAN FRANCISCO / Feb 22, 2024 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that it will participate in the following upcoming investor events.
Raymond James 45th Annual Institutional Investors Conference
Date: March 5, 2024
Fireside Chat Time: 2:50 pm ET/11:50 am PT
Speaker: Anna Bryson, Chief Financial Officer
Barclays 26th Annual Global Healthcare Conference
Date: March 13, 2024
Fireside Chat Time: 11:15 am ET/8:15 am PT
Speaker: Anna Bryson, Chief Financial Officer
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The Company's network members include over 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients. For more information, visit www.doximity.com.
| Last Trade: | US$51.66 |
| Daily Change: | 0.69 1.35 |
| Daily Volume: | 310,110 |
| Market Cap: | US$7.100B |
November 06, 2025 August 07, 2025 August 07, 2025 | |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORE
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
